Miguel A. Escobar, MD, is a board-certified and fellowship-trained hematologist specializing in treating hemophilia, thrombophilia, and other congenital and acquired bleeding and clotting disorders. He’s also a professor at McGovern Medical School at UTHealth Houston, where he is the director of outpatient and inpatient anticoagulation services and the Clinical Research Unit co-director. In a research career spanning 20 years, he has participated in numerous multicenter clinical studies nationally and internationally. He also partners extensively with academia and industry in running collaborative studies and as a clinical investigator. His research interests include hemophilia and inhibitors, general hemostasis, thrombophilia, and venous thromboembolism. Escobar has received numerous teaching awards and has contributed extensively to the literature clinically and scientifically on numerous subjects concerning bleeding and clotting disorders.